0001192482-18-000460.txt : 20181017
0001192482-18-000460.hdr.sgml : 20181017
20181017162758
ACCESSION NUMBER: 0001192482-18-000460
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181015
FILED AS OF DATE: 20181017
DATE AS OF CHANGE: 20181017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heffernan Michael Thomas
CENTRAL INDEX KEY: 0001448914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 181126634
MAIL ADDRESS:
STREET 1: C/O CORNERSTONE THERAPEUTICS INC.
STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250
CITY: CARY
STATE: NC
ZIP: 27518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-10-15
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001448914
Heffernan Michael Thomas
C/O COLLEGIUM PHARMACEUTICAL, INC.
780 DEDHAM STREET, SUITE 800
CANTON
MA
02021
1
0
0
0
Common Stock
2018-10-15
4
S
0
25000
16.53
D
361000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2018.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.40 to $16.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2).
/s/ Paul Brannelly as Attorney-In-Fact For Michael T. Heffernan
2018-10-17